Recro Pharma, Inc. Insider Trading for May 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Recro Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Recro Pharma, Inc. for May 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2020 | REPH | Recro Pharma, Inc. | Ajdler Arnaud | Director | Option Exercise | A | 8.37 | 12,405 | 103,830 | 12,405 | |
| May 11 2020 | REPH | Recro Pharma, Inc. | Ajdler Arnaud | Director | Grant | A | 0.00 | 8,363 | 0 | 23,757 | 15.4 K to 23.8 K (+54.33 %) |
| May 11 2020 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 8.37 | 12,405 | 103,830 | 12,405 | |
| May 11 2020 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Grant | A | 0.00 | 8,363 | 0 | 58,059 | 49.7 K to 58.1 K (+16.83 %) |
| May 11 2020 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Option Exercise | A | 8.37 | 12,405 | 103,830 | 12,405 | |
| May 11 2020 | REPH | Recro Pharma, Inc. | Reasons Bryan M. | Director | Grant | A | 0.00 | 8,363 | 0 | 40,506 | 32.1 K to 40.5 K (+26.02 %) |
| May 11 2020 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 8.37 | 12,405 | 103,830 | 12,405 | |
| May 11 2020 | REPH | Recro Pharma, Inc. | Ashton William | Director | Grant | A | 0.00 | 8,363 | 0 | 53,357 | 45 K to 53.4 K (+18.59 %) |
| May 11 2020 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Option Exercise | A | 8.37 | 12,405 | 103,830 | 12,405 | |
| May 11 2020 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Grant | A | 0.00 | 8,363 | 0 | 49,623 | 41.3 K to 49.6 K (+20.27 %) |
| May 11 2020 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Option Exercise | A | 8.37 | 12,405 | 103,830 | 12,405 | |
| May 11 2020 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Grant | A | 0.00 | 8,363 | 0 | 51,059 | 42.7 K to 51.1 K (+19.59 %) |